Curr Oncol. 2008 Aug;15(4):188-92.

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?

Bonfil RD, Fridman R, Mobashery S, Cher ML.

Source

Department of Urology, Wayne State University School of Medicine, and The Barbara Ann Karmanos Cancer Institute, Detroit, MI, U.S.A. dbonfil@med.wayne.edu

PMID:: 18769612; [PubMed]
PMCID:: PMC2528310

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Review [Bony lesion with prostate cancer]. [Clin Calcium. 2008]
Review [Bony lesion with prostate cancer].
Kamiya N, Suzuki H, Kawamura K, Imamoto T, Ichikawa T. Clin Calcium. 2008 Apr; 18(4):431-7.
Review The role of osteoclastic activity in prostate cancer skeletal metastases. [Drugs Today (Barc). 2002]
Review The role of osteoclastic activity in prostate cancer skeletal metastases.
Keller ET. Drugs Today (Barc). 2002 Feb; 38(2):91-102.
Review Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. [J Urol. 2005]
Review Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW, Baseman A, Assikis V, Zhau HE. J Urol. 2005 Jan; 173(1):10-20.
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. [J Natl Cancer Inst. 2002]
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, Bhagat S, Mullins C, Fridman R, Cher ML. J Natl Cancer Inst. 2002 Jan 2; 94(1):17-25.
Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells. [Invasion Metastasis. 1997]
Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC, Hirte HW, Singh G. Invasion Metastasis. 1997; 17(6):312-22.

See reviews... See all...

Cited by 1 PubMed Central article

Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration. [Cancer Res. 2010]
Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.
Sabbota AL, Kim HR, Zhe X, Fridman R, Bonfil RD, Cher ML. Cancer Res. 2010 Jul 1; 70(13):5558-66. Epub 2010 Jun 15.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer b...
Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
Curr Oncol. 2008 Aug ;15(4):188-92.

PubMed
Impact and outcomes of an Iyengar yoga program in a cancer centre.
Impact and outcomes of an Iyengar yoga program in a cancer centre.
Curr Oncol. 2008 Aug ;15 Suppl 2:s109.es72-8.

PubMed
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheime...
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
PLoS One. 2008 Sep 4 ;3(9):e3135.

PubMed
Listening to Mothers II: Report of the Second National U.S. Survey of Women's Ch...
Listening to Mothers II: Report of the Second National U.S. Survey of Women's Childbearing Experiences: Conducted January-February 2006 for Childbirth Connection by Harris Interactive(R) in partnership with Lamaze International.
J Perinat Educ. 2007 Fall ;16(4):9-14.

PubMed
Integrated genomics identifies five medulloblastoma subtypes with distinct genet...
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
PLoS One. 2008 Aug 28 ;3(8):e3088.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?

Source

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information